ICHS’ new phone system will help you make appointments faster

ICHS Phone

As part of ICHS’ ongoing efforts to provide our patients a better care experience, we are upgrading our phone system to make it faster for you to reach your care team. 

Effective immediately, the new phone system allows for you to call the clinic department and services you want to reach with a few pushes of a button. When you call your ICHS clinic, you can now choose the medical, dental, pharmacy or billing departments and direct your calls to make an appointment, ask about eligibility, find medical records, and request a referral. 

The upgraded phone system replaces the current phone system so there are no changes to ICHS phone numbers.


When you call:

  • Medical: Press 1, and then:
      • To make an appointment, press 1
      • To ask about eligibility, press 2
      • To find medical records, press 3
      • To request a referral, press 4
  • Dental: Press 2, and then:
      • To make an appointment, press 1
      • To find medical records, press 2
  • Pharmacy: Press 3
  • Billing: Press 4
  • Have other questions? Please stay on the line and your call will be answered.

Thank you for allowing ICHS to partner with you for your good health. We look forward to connecting with you soon.

Phone Tree

Johnson & Johnson COVID-19 Vaccine Update

Visit the DOH Prioritization Guidance Webpage to check vaccine eligibility. Eligible ICHS patients, call 206-788-3700 to schedule your COVID-19 vaccine appointment today. If you are not an ICHS patient, please don’t contact our call center. Your appointment must be made online.

Johnson & Johnson Vaccine

On April 13, the CDC and FDA recommended a pause in administering the Johnson & Johnson (Janssen) COVID-19 vaccine. The pause is a safety protocol taken out of an abundance of caution while medical and public health experts examine data for six cases reported in the U.S. of blood clots in individuals after receiving the Janssen vaccine. 

All six cases were women aged 18-48 who developed extremely rare but serious brain blood clots six to 13 days after receiving the Janssen vaccine. These cases represent a fraction of a percent of the 6.8 million people in the United States who have received the Janssen vaccine. 

Anyone who received the Janssen vaccine and experiences severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact their health care provider.

ICHS has been delivering Moderna COVID-19 vaccines since Dec. 2020 and Janssen vaccines since March 2021. 

This pause in administering the Janssen vaccine reflects an ongoing process to keep safety as a top priority when it comes to all COVID-19 vaccines. During this pause, ICHS continues to work with public health and community partners to administer Moderna vaccines to protect patients and community members.

For the most recent updates, please visit: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/JJUpdate.html 

For ICHS’ vaccine frequently asked questions page please visit: https://www.ichs.com/covid-19-vaccine-update/ 

 

Additional resources

Visit the Public Health – Seattle & King County website for the latest information and updates about vaccine development and distribution.

COVID-19 Vaccines | CDC

Vaccine Information: Washington State Department of Health

COVID-19 Vaccines | FDA

ICHS Statement on Anti-Asian Hate

On March 25, 2021, International Community Health Services (ICHS) released the following statement on Anti-Asian Racism. ICHS denounces the increased violence targeting Asians and Asian Americans and recognize that the killings on March 16 in Atlanta of six Asian American women working to support their families or themselves are the most extreme example of anti-Asian hate, a continuation and expansion of racist actions against Black, Native and Latinx peoples. Our legacy obliges us to keep fighting for social justice, challenging racism and championing health equity.


Stop Asian Hate

Excerpt from the statement:

“International Community Health Services (ICHS) condemns racism and discrimination in all forms upon all marginalized communities. ICHS particularly denounces the increased violence targeting Asians and Asian Americans.”

“Racism is a public health crisis. Improving health outcomes requires addressing structural barriers and circumstances that harm our patients and communities. We must continue to work collectively for human and civil rights, examine our own racial biases and privileges, and extend our support to members of our community who no longer feel safe.  As a healthcare organization, we must continue to live, defend, and grow our vision and mission.”

ICHS Bắt đầu Tiêm Thuốc chủng ngừa Johnson & Johnson COVID-19

Vy Hà được tiêm vắc xin Johnson & Johnson COVID-19 một liều tại Phòng khám Shoreline của Dịch vụ Y tế Cộng đồng Quốc tế vào Thứ Ba.

Vy Hà đã rất mong được trở lại cảm giác bình thường như gặp lại gia đình và trở lại văn phòng làm việc.

Vào ngày 9 tháng 3, Hà đến hẹn tiêm vắc-xin COVID-19 tại Phòng khám Shoreline của Dịch vụ Y tế Cộng đồng Quốc tế (ICHS). Đây là ngày đầu tiên ICHS sử dụng vắc xin Johnson & Johnson (J&J) mới được cho phép.

Sự xuất hiện của vắc-xin J&J đồng nghĩa với việc nhiều vắc-xin được cung cấp  hơn. Các tính năng của nó cũng là một tin lớn đối với các chuyên viên y tế, khi chỉ cần tiêmmột liều và các yêu cầu bảo quản dễ dàng hơn. Dữ liệu lâm sàng về vắc-xin J&J đã mang lại nhiều câu hỏi khi mọi người cố gắng so sánh vắc-xin để quyết định loại vắc-xin nào tốt nhất cho họ.

Hà cho biết cô cảm thấy “không cần kén chọn” về bất cứ loại vắc xin nào cô nhận được. Cuối cùng thì đây là cơ hội để cô bảo vệ gia đình mình và giúp ngăn chặn sự lây lan của COVID-19. “Điều này dựa trên cơ sở khoa học,” Hà nói, “Vì vậy, cá nhân tôi cảm thấy tự tin về nó. Năm nào tôi cũng tiêm phòng cúm nên cần không đặt trước.

Quyền lựa chọn thứ ba

Paul Nguyen
Paul Nguyễn, chuẩn bị một liều vắc xin Johnson & Johnson COVID-19.

Việc triển khai vắc-xin COVID-19 ở WA đã được mở rộng. Tính đến ngày 9 tháng 3, hơn hai triệu liều vắc-xin đã được phân phối tại WA và hiện chúng tôi đang vượt mục tiêu của DOH là 45.000 lần tiêm chủng mỗi ngày.

Mùa hè năm ngoái, có vẻ như một loại vắc-xin COVID-19 hiệu quả sẽ còn phải chờ nhiều năm nữa. Nhưng giờ đây, sau những nỗ lực kết hợp của các chuyên gia y tế và hàng chục nghìn tình nguyện viên, Hoa Kỳ hiện có ba loại vắc xin hiệu quả cao để ngăn chặn sự lây lan của dịch bệnh: Johnson & Johnson, Pfizer và Moderna.

Vắc xin J&J là loại vắc xin gần đây nhất được phê duyệt. Các thử nghiệm lâm sàng vắc xin đã được Cơ quan Quản lý Dược phẩm Liên bang xem xét và phê duyệt vào ngày 27 tháng 2. Sau đó Nhóm công tác Đánh giá An toàn Khoa học các Bang miền Tây đã xem xét và cho phép vào ngày 3 tháng 3. Trong số 44.000 bệnh nhân tham gia thử nghiệm vắc xin J&J, không ai trong số họ phải nhập viện vì COVID-19.

Các kết quả lâm sàng khả quan làm hài lòng Lakshmi Deepa Yerram, MD, giám đốc y tế ICHS. “Khả năng của vắc xin J&J trong việc ngăn ngừa bệnh nặng, nhập viện và tử vong,” “có thể so sánh với vắc xin Pfizer và Moderna.” Yerram nói.  Cô mô tả loại vắc xin thứ ba bổ sung thêm công cụ trong kho vũ khí để chống lại đại dịch COVID-19.

Các câu hỏi và sự hủy bỏ hẹn

Paul Nguyen, người giám sát phòng thuốc tây của ICHS Shoreline, đã tiêm vắc xin COVID-19 kể từ tháng Giêng.  Anh là người tiêm vắc-xin vào ngày 9 tháng 3 và đã nói chuyện với những bệnh nhân từ chối vắc-xin J&J

Nguyễn chia sẻ: “Một trong những điều đã nảy sinh là sự lưỡng lự của bệnh nhân khi nói đến tỷ lệ hiệu quả so với thuốc chủng ngừa Moderna và Pfizer.”

Các thuốc chủng ngừa Moderna và Pfizer có vẻ như cung cấp khả năng bảo vệ tốt hơn chống lại COVID-19 khi chỉ xem xét dữ liệu thu thập được trong các thử nghiệm lâm sàng tại Hoa Kỳ. Johnson & Johnson đạt hiệu quả 72% so với hiệu quả khoảng 95% của hai loại còn lại.

Từ những con số này đối với một số bệnh nhân có hẹn tiêm vắc-xin, họ suy ra rằng vắc-xin J&J kém hơn. Nhiều người đã đặt câu hỏi cho Nguyên. Một số bệnh nhân đã hủy bỏ cuộc hẹn của họ.

Tuy nhiên, những con số hiệu quả đó không nói lên toàn bộ câu chuyện. Tất cả các loại vắc xin đều được thử nghiệm khác nhau và sử dụng các mục tiêu khác nhau để xác định hiệu quả, khiến cho việc so sánh gần như không thể thực hiện được, Nguyen giải thích. Các loại vắc-xin cũng được thử nghiệm vào các thời điểm khác nhau trong đại dịch. Nguyễn cho biết: “Thật giống như so sánh trái táo với trái cam.

Cả ba loại vắc-xin đều có hiệu quả 100% cho điều quan trọng nhất – ngăn ngừa tử vong, bệnh nặng và nhập viện.

“Tôi đã chờ đợi vắc xin J&J”

Kathleen Vasen ICHS vaccine recipient
Kathleen Vasen đã chờ đợi vắc-xin Johnson & Johnson COVID-19 một liều.

Kathleen Vasen, một nhân viên y tế đã nghỉ hưu, rất vui khi cuối cùng đã được tiêm vắc xin. “Tôi đã chờ đợi vắc-xin J&J,” Vasen giải thích, “Một vì đó là vắc-xin một mũi và hai là vì cách sản xuất nó giống với cách tiêm vắc-xin cúm và v.v. “đã không bao giờ có vấn đề.”

Dự kiến sẽ có một thành viên mới trong gia đình vào tháng tới , Vasen cho biết việc tiêm vắc-xin J&J một liều có nghĩa là bà sẽ được bảo vệ “đúng thời điẻm” ở đó để “nhìn và ôm cháu trai mới của tôi”.

Loại vắc-xin một mũi này rất thú vị đối với Yerram. Tuy nhiên, bà nói rằng loại vắc xin tốt nhất là loại có sẵn cho bạn vì tất cả các loại vắc xin đều cực kỳ hiệu quả khi ngăn ngừa các trường hợp nghiêm trọng và tử vong do COVID-19.

Các chuyên gia y tế lo ngại về sự lây lan của các biến thể mới của COVID-19, có khả năng lây nhiễm cao hơn và có khả năng dẫn đến một sự gia tăng các ca bệnh khác. Nhận được “sự bảo vệ đầy đủ sớm hơn” sẽ bảo vệ bạn và những người xung quanh bạn. “Vui lòng chủng ngừa càng sớm càng tốt, với bất kỳ thuốc hiệu nào có sẵn cho bạn,” Yerram nói.

 


Để tìm hiểu xem bạn hiện có đủ điều kiện để nhận vắc xin hay không, hãy sử dụng Công cụ Tìm tới lượt mình qua Phase Finder của DOH. Nó có dịch sẵn bằng nhiều ngôn ngữ: https://www.doh.wa.gov/Emergencies/COVID19

Để tìm hiểu thêm về vắc xin COVID-19 và cách đặt lịch hẹn, vui lòng truy cập: https://www.ichs.com/covid-19-vaccine-update/

ICHS Begins Administering Johnson & Johnson COVID-19 Vaccine

Vy Ha, ICHS Vaccine Recipient
Vy Ha gets a one-dose Johnson & Johnson COVID-19 vaccine at the International Community Health Services Shoreline Clinic on Tuesday.

Vy Ha has been looking forward to getting back to a sense of normalcy like seeing her family and being back in the office.

On March 9, Ha arrived for her COVID-19 vaccine appointment at International Community Health Services (ICHS) Shoreline Clinic. It was ICHS’s first day administering the recently authorized Johnson & Johnson (J&J) vaccine.

The arrival of J&J vaccine means more vaccine supply. Its features have also been big news for health professionals, having to require only one-dose and having easier storage requirements. Clinical data on the J&J vaccine has brought questions as people have tried to compare vaccines to decide which is ‘best’ for them.

Ha said she felt ‘neutral’ about which vaccine she received. After all, this was her opportunity to protect her family and help prevent the spread of COVID-19. “This is based on science,” says Ha, “So, I personally feel confident about it. I do a yearly flu shot every year, so I don’t have reservations.”

The third option

The COVID-19 vaccine rollout in WA has been expanding. As of March 9, over two million vaccine doses have been delivered in WA and we are now exceeding the DOH goal of 45,000 vaccinations a day. (DOH)

Last summer, it seemed that an effective COVID-19 vaccine would be years away. But now, after the combined efforts of health professionals and tens of thousands of volunteers, the U.S. now has three highly effective vaccines to stop the spread of the disease: Johnson & Johnson, Pfizer, and Moderna.

The J&J vaccine is the most recent to be approved. The vaccine clinical trials were reviewed and approved by the Federal Drug Administration on February 27. Then the Western States Scientific Safety Review Workgroup reviewed and authorized it on March 3. Of the 44,000 patients who joined the J&J vaccine trials, none of them were hospitalized from COVID-19.

The positive clinical results pleased Lakshmi Deepa Yerram, MD, ICHS medical director. “The J&J vaccine’s ability in preventing severe disease, hospitalization, and death,” Yerram said, “is comparable to the Pfizer and Moderna vaccines.” She described the third vaccine as adding more tools in the arsenal against fighting the COVID-19 pandemic.

Questions and cancellations

Paul Nguyen
Paul Nguyen, preparing a dose of Johnson & Johnson COVID-19 vaccine.

Paul Nguyen, ICHS Shoreline Clinic pharmacist supervisor, has been administering COVID-19 vaccines since January. He was the one administering vaccines on March 9 and spoke to patients who refused the J&J vaccine.

“One of the things that has come up,” shares Nguyen, “is patients’ hesitancy when it comes to efficacy rate compared to the Moderna and Pfizer vaccines.”

The Moderna and Pfizer vaccines appear to offer better protection against COVID-19 when just looking at the data collected during U.S. clinical trials. The Johnson & Johnson reached a 72% effectiveness compared to the roughly 95% effectiveness of the other two.

For some vaccine patients, these numbers infer that the J&J vaccine is inferior. Many had questions for Nguyen. Some patients cancelled their appointments.

However, those effectiveness numbers do not tell the whole story. All the vaccines were tested differently and used different goal posts to determine effectiveness, making comparisons nearly impossible, Nguyen explained. The vaccines were also tested at different times in the pandemic. “It’s kind of comparing apples to oranges,” Nguyen said.

All three vaccines are 100% effective in the way that matters most – preventing death, serious illness and hospitalization.

“I’ve been waiting for the J&J vaccine”

 

Kathleen Vasen ICHS vaccine recipient
Kathleen Vasen has been waiting for the one-dose Johnson & Johnson COVID-19 vaccine.

Kathleen Vasen, a retired health worker, was pleased to finally be vaccinated. “I’ve been waiting for the J&J vaccine,” Vasen explained, “One because it’s a one-shot vaccine and two, because of the way that it’s manufactured is the same as what is done for flu shots and so forth of which I’ve never had an issue.”

With a new family member expected next month, Vasen said having the one-dose J&J vaccine means she will be protected in “just the right amount of time” to be there to “see and hold my new grandson.”

This one-shot vaccine is exciting for Yerram. However, she said that the best vaccine is the one that is available to you because all vaccines are extremely effective when it comes to preventing severe and fatal cases of COVID-19.

Health experts are concerned over the spread of new variants of COVID-19, being more infectious and potentially leading to another surge in cases. Getting “sufficient protection sooner” protects you and the people around you. “Please get the vaccine as soon as possible, and any brand that is available to you,” Yerram said.

 


To find out if you currently qualify to receive the vaccine, use the DOH PhaseFinder. It is available in multiple languages here: https://www.doh.wa.gov/Emergencies/COVID19

To learn more about COVID-19 vaccines and how to make an appointment please visit: https://www.ichs.com/covid-19-vaccine-update/

ICHS Foundation raises over $38,000 in the first virtual edition of the Lunar New Year 5k

Lunar New Year Virtual 5k Cover

ICHS Lunar New Year Virtual 5k

Participants from across the country joined together to raise money for free and low-cost health services for International Community Health Services patients.

ICHS Foundation raised $38,736 in the first-ever Lunar New Year Virtual 5k last week. Over 350 participants ran and walked courses of their own choosing, while practicing social distancing in this experimental fundraising event for ICHS Foundation. All the proceeds will fund free and low-cost health services for ICHS patients who otherwise would not be able to afford them.

Running together, safely apart

During the COVID-19 pandemic, in-person events have been cancelled to decrease the spread of the virus. At the same time, many ICHS patients have lost health insurance at a time when access to health services are paramount. In order to continue this year’s Lunar New Year 5k to support our patients in a way that would keep participants safe, the planning committee pivoted to a new event format – a virtual 5k.

A new experience

As a virtual event, the Lunar New Year Virtual 5k was planned to provide flexibility for participants to run safely. Rather than a set course on a specific day, participants completed their 5k runs or walks along the course of their own choosing throughout the week. Some participants took a walk in their local neighborhoods, others ran along the old race course on the Interurban Trail in Shoreline, and others completed trail runs in Grand Canyon, Arizona.

The event reached two milestones. The first being the widest age range with participants age 1 to 93 joining in the event. The other, being the most wide-reaching participation ever for ICHS Foundation with participants running in 15 states!

To continue the camaraderie and celebration, the virtual 5k also connected with the community on social media. Participants shared selfies and course photos wearing their event t-shirts and using the hashtag #ICHSLNY5k. ‘Running together, safely apart’ became the central message of the race as social media pages filled with photos of participants sharing in their commitment to the cause and completion of the race.

As our communities continue to be resilient through the challenges of the COVID-19 pandemic, this February has also been a time of hope as ICHS has continued to distribute COVID-19 vaccines to our most vulnerable. Despite the challenges we all face together, ICHS Foundation continues to bring together the community to support the mission of health equity and access for ICHS patients.

We look forward to seeing you next year – the Year of the Tiger!

 

We extend our gratitude to our generous 2021 Lunar New Year Virtual 5k sponsors:

 

PLATINUM SPONSOR ($7,500):

Columbia Bank logo

 

GOLD SPONSORS ($5,000):

Super jock 'n jill logo

 

SILVER SPONSORS ($2,500):

Amerigroup

Arcora Foundation

Kaiser Permanente Logo

 

BRONZE SPONSORS ($1,000):

Denise Louie Education Center

Molina Healthcare of Washington

Rainier Vehicle and Vessel Licensing ($1,500 contribution)

Seattle Gummy Company

State secretary of health at ICHS to discuss COVID-19 vaccine

Dr. Umair A. Shah, Washington state secretary of health, visits ICHS

On Jan. 12, as COVID-19 vaccine efforts ramp up in Washington state and across the nation, leaders from International Community Health Services (ICHS) welcomed Dr. Umair A. Shah, Washington state secretary of health, to the health center’s International District Clinic.

The meeting opened opportunities for ICHS to raise issues as staff and providers look ahead to the next phases of Washington state’s vaccine rollout, which will continue to target those at highest risk. ICHS received the first doses of the Moderna vaccine on Dec. 23, vaccinating front line health workers and residents in its senior congregate care facility, ICHS Legacy House.

“Our successful end to the pandemic is critically tied to the efficient and equitable distribution of the vaccine,” said Teresita Batayola, ICHS CEO, “As a community health center, ICHS will be key in helping those most at risk overcome language, culture, income and vaccine misinformation barriers that could prevent them from getting vaccinated. We are honored to welcome Dr. Shah to our International District Clinic. Today’s meeting was a productive step in coordinating public, private and community efforts to make sure we inform and reach everyone.”

The secretary released a statement, “Dr. Shah applauds the important work ICHS has done to ensure people in King County’s diverse communities (and beyond) have access to quality, affordable health care, including COVID-19 testing, during the pandemic. ICHS contributions will help ensure an equitable, culturally responsive, and efficient distribution of Washington state’s supply of COVID-19 vaccine so that no one – no matter where they live, their racial or ethnic background, their income, language, or immigration or insurance status – is left behind.”

ICHS receives first delivery of COVID-19 vaccines

ICHS staff COVID19 vaccinations

On Dec. 23, International Community Health Services (ICHS) was among the first of the area’s health centers to receive doses of the COVID-19 vaccine and begin vaccinating frontline health workers.

Reactions were jubilant, as staff saw the end of a challenging year and the nation’s largest health crisis, come into sight.

Ping Yang receives COVID19 vaccine
Ping Yang, ICHS acupuncturist

“The shot has no pain at all for me,” said Ping Yang, acupuncturist, first to be delivered the vaccine at the International District Clinic. “At last I don’t have to worry, because I’m seeing patients every time and no one knows who is carrying what. The vaccine is good for me, my family, my community and hopefully I can visit my parents, they are 97 years old.

Community members can be confident that the vaccine is safe and that it works, said Dr. Asqual Getaneh, ICHS chief medical officer. “I enthusiastically rolled up my sleeve to be vaccinated and urge everyone to do the same. It is the best way to look out for yourself, your family and your community. I will now be able to spend Christmas with my 89-year-old father with additional protection and without great anxiety. This is how we stop people from dying and return to normal life.”

The vials of the Moderna vaccine are a milestone in ending the pandemic. Initial supplies will be limited and given to groups at highest risk, such as health care workers and people in long-term care facilities, said Getaneh. The next priority groups will be essential workers with higher risk of exposure, adults with underlying health conditions and adults 65 years and older. Eventually there will be enough for everyone who wants a vaccination. She urged patience, as well as offered a reminder there will still be a need to wear a mask, maintain distancing and practice good hygiene for some time.

In February 2020, ICHS was the first community health center in the nation to see a positive COVID-19 diagnosis. As a result, ICHS has helped set best practices guiding the response of the nation’s nearly 1,400 federally qualified health centers, which collectively serve 30 million people, most of them low income, immigrants and refugees.


For more information

Visit the Public Health – Seattle & King County website for the latest information and updates about vaccine development and distribution.

We encourage you to talk to your ICHS doctor about the vaccine’s benefits. Please visit our page with COVID-19 vaccine updates to learn more. 

Run your own way in the 2021 Lunar New Year Virtual 5k

Lunar New Year Virtual 5k 2021 ICHSICHS Foundation today opened registration for the annual 2021 Lunar New Year 5k at www.ichs.com/5k.

Beginning on the first week of the Lunar New Year Feb 12th – 18th, the Lunar New Year Virtual 5k’s new format provides more flexibility for participation. Registrants choose their own course and personal day to race, while encouraging safely physically distancing during the ongoing COVID-19 pandemic.

Race proceeds fund patient health care access

All race proceeds will fund patient health services for families who could not otherwise afford them.

“Its been a tough year, and ICHS has been on the frontlines caring for patients and our communities.” says Ron Chew, ICHS Foundation Director, “This event is a way for us all to celebrate a new, better year ahead and support our patients.”

The event is hosted by the ICHS Foundation, a separate non-profit that fundraises year round to support ICHS’s patients with free or low-cost health services. The COVID-19 pandemic and disruptions to the health insurance coverage for many Washington residents highlights the importance of providing affordable health care access to anyone who needs it.

Registration is now open

The Lunar New Year Virtual 5k is open to all ages. Participants run or walk the course of their choice during the first week of the Lunar New Year (Feb. 12-18, 2021). Registration is $35 with an early bird discounted price of $30 ending Jan. 12, 2021. Attendees under 14 or 65 and older can participate for free.